1. Home
  2. JWEL vs ENSC Comparison

JWEL vs ENSC Comparison

Compare JWEL & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JWEL
  • ENSC
  • Stock Information
  • Founded
  • JWEL 2012
  • ENSC 2003
  • Country
  • JWEL China
  • ENSC United States
  • Employees
  • JWEL N/A
  • ENSC N/A
  • Industry
  • JWEL Other Consumer Services
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • JWEL Consumer Discretionary
  • ENSC Health Care
  • Exchange
  • JWEL Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • JWEL 5.2M
  • ENSC 5.2M
  • IPO Year
  • JWEL 2021
  • ENSC N/A
  • Fundamental
  • Price
  • JWEL $2.20
  • ENSC $2.24
  • Analyst Decision
  • JWEL
  • ENSC
  • Analyst Count
  • JWEL 0
  • ENSC 0
  • Target Price
  • JWEL N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • JWEL 23.8K
  • ENSC 92.0K
  • Earning Date
  • JWEL 08-05-2025
  • ENSC 08-13-2025
  • Dividend Yield
  • JWEL N/A
  • ENSC N/A
  • EPS Growth
  • JWEL N/A
  • ENSC N/A
  • EPS
  • JWEL N/A
  • ENSC N/A
  • Revenue
  • JWEL $132,981,531.00
  • ENSC $6,224,081.00
  • Revenue This Year
  • JWEL N/A
  • ENSC N/A
  • Revenue Next Year
  • JWEL N/A
  • ENSC $1,381.48
  • P/E Ratio
  • JWEL N/A
  • ENSC N/A
  • Revenue Growth
  • JWEL N/A
  • ENSC 256.35
  • 52 Week Low
  • JWEL $1.18
  • ENSC $1.62
  • 52 Week High
  • JWEL $3.71
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • JWEL 49.79
  • ENSC 52.50
  • Support Level
  • JWEL $2.02
  • ENSC $2.08
  • Resistance Level
  • JWEL $2.50
  • ENSC $2.27
  • Average True Range (ATR)
  • JWEL 0.23
  • ENSC 0.17
  • MACD
  • JWEL -0.03
  • ENSC 0.01
  • Stochastic Oscillator
  • JWEL 29.03
  • ENSC 62.79

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: